LGD-3303

• CAT Number: I011845
• CAS Number: 917891-35-1
• Molecular Formula: C16H14ClF3N2O
• Molecular Weight: 342.74
• Purity: ≥95%
• Synonyms: LGD 3303; 9-Chloro-2-ethyl-3,6-dihydro-1-methyl-3-(2,2,2-trifluoroethyl)-7H-pyrrolo[3,2-f]quinolin-7-one
• Target: Androgen receptor
• Storage: RT
• IUPAC Name: 9-chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-6H-pyrrolo[3,2-f]quinolin-7-one
• InChI: InChI=1S/C16H14ClF3N2O/c1-3-11-8(2)14-12(22(11)7-16(18,19)20)5-4-10-15(14)9(17)6-13(23)21-10/h4-6H,3,7H2,1-2H3,(H,21,23)
• InChIKey: OMXGOGXEWUCLFI-UHFFFAOYSA-N
• SMILES: CCC1=C(C2=C(N1CC(F)(F)F)C=CC3=C2C(=CC(=O)N3)Cl)C

LGD-3303（Cat No.:I011845）is a selective androgen receptor modulator (SARM) under investigation for its potential use in treating conditions like muscle wasting, osteoporosis, and sarcopenia. It works by binding to androgen receptors in muscle and bone tissues, mimicking the effects of anabolic steroids, such as promoting muscle growth and bone density, without the adverse side effects typically associated with traditional anabolic steroids. LGD-3303 is being studied for its ability to improve physical performance, strength, and overall quality of life in patients with degenerative conditions, though it is still in early clinical stages.